TARIFFS LATEST US, China to slash tariffs for 90 days OTC Markets OTCQX - Delayed Quote • USD Vaso Corporation (VASO) Follow Add holdings 0.1400 +0.0060 +(4.48%) At close: May 9 at 4:00:00 PM EDT All News Press Releases SEC Filings CORRECTION - Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024 The Company Reports Continued Growth in Annual RevenuePLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Please note that, in a release issued under the same headline earlier today by Vaso Corporation (OTCQX: VASO), some figures in the written description of the financial results for the three months and the full year were misstated. All figures in the financial tables were correct. The corrected release follows: Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversif Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024 The Company Reports Continued Growth in Annual RevenuePLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months and year ended December 31, 2024. “Continuing the trend of top-line growth, the Company’s annual revenue reached another record Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology and MedTech, today announced new executive appointments to the Vaso management team and Board of Directors, effective January 1, 2025. Jane Moen was appointed Vaso Corporation’s Chief Operating Officer. She will continue in her role as President of VasoHealthcare, a Vaso Corporation subsidiary. Ms. Moen has served as a Director of Vaso Corporation’s Board s Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology and MedTech, today released a letter to shareholders and employees summarizing the company’s achievements throughout the year and outlining key strategic developments and priorities for the upcoming year. Highlights in the letter include opera Vaso Corporation Announces Financial Results for Third Quarter 2024 PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today reported its operating results for the three months ended September 30, 2024. “For the third quarter of 2024, the Company’s revenue was $20.8 million, an increase of 7% when compared to the prior year’s third quarter revenue of $19.4 mi Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I (“Achari”) to terminate the Business Combination Agreement with Achari. The Company will continue to seek opportunities to increase stockholder value, including through internal growth, new partnerships, and strategic investments with a concentration on medical and IT service companies. About Vaso Corporation Vaso Corporation Vaso Corporation Announces Date Change for Its Stockholders Meeting PLAINVIEW, N.Y., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced that at its special stockholders meeting on August 26, 2024, the meeting was adjourned without any consideration of the proposals to 10:00 AM Eastern on September 10, 2024 at the same location, the Lever House located at 390 Park Avenue, New York, NY 10022. With the adjourned date being well after the Labor Day holiday, it will provide more stockholders with the opportunity to attend the st Vaso Corporation Announces Financial Results for Second Quarter 2024 High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended June 30, 2024. “The Company recorded a total revenue of $20.2 million for the second quarter of 2024, in line with revenue of $20.3 million for the second quarter of 2023,” commented Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation. “Deferre Vaso Corporation Announces the Effectiveness of the Achari Ventures Holdings Corp. I Registration Statement on Form S-4 A significant milestone for Vaso’s Listing on NASDAQ Vaso Stockholders Meeting Scheduled for August 26, 2024 to Approve Business Combination with Achari PLAINVIEW, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso” or the “Company”) (OTCQX: VASO) announced that on August 5, 2024, the U.S. Securities and Exchange Commission (“SEC”) declared effective the Achari Ventures Holdings Corp. I (“Achari”) (NASDAQ: AVHI) Registration Statement on Form S-4, as amended (the “Registration State Vaso Corporation Announces Financial Results for First Quarter 2024 PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. “Total revenue for the first quarter of 2024 was $18.7 million, a decrease of $0.3 million or 1.6% when compared to the same quarter last year, mainly due to lower sales in the equipment segment. Quarterly gross profit was $10.9 million, a decrease of $0.6 million or 5.6% year-over-year, as a result of lower revenue and lower gr Performance Overview Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return VASO S&P 500 (^GSPC) YTD +16.67% -3.77% 1-Year -44.00% +8.55% 3-Year +100.00% +41.81%